Konwisorz, Anna and Springwald, Anette and Haselberger, Martina and Goerse, Regina and Ortmann, Olaf and Treeck, Oliver (2010) Knockdown of ICB-1 gene enhanced estrogen responsiveness of ovarian and breast cancer cells. ENDOCRINE-RELATED CANCER, 17 (1). pp. 147-157. ISSN 1351-0088, 1479-6821
Full text not available from this repository. (Request a copy)Abstract
ICB-1 chromosome 1 open reading frame 38 (C1orf38) is a human gene initially described by our group to be involved in differentiation processes of cancer cells. Recently, we have reported ICB-1 as a novel estrogen target gene and identified an estrogen response element in its promoter. In this study, we examined the role of ICB-1 in regulation of proliferation of breast and ovarian cancer cells. We knocked down its expression in estrogen-dependent MCF-7 breast cancer cells and hormone-unresponsive SK-OV-3 ovarian cancer cells by stable transfection with a specific shRNA plasmid followed by G-418 selection. Knockdown of ICB-1 enabled a considerable estrogen response of SK-OV-3 cells in terms of proliferation. This transformation of SK-OV-3 cells into an estrogen-responsive phenotype was accompanied by upregulation of estrogen receptor alpha (ER alpha) expression and a significant decrease of ER beta expression on the mRNA level. Expression of ER alpha-dependent genes progesterone receptor, pS2, fibulin 1c, and c-fos was elevated in SK-OV-3 cells stably expressing ICB-1 shRNA. In MCF-7 cells, ICB-1 knockdown exerted similar effects on gene expression, supporting a general role of ICB-1 in estrogen responsiveness. Our data suggest that differentiation-associated gene ICB-1 might exert antagonistic actions on cellular estrogen response, which can result in inhibition of estradiol-triggered proliferation. The molecular mechanisms mediating this inhibitory effect of ICB-1 on estrogen signaling are suggested to be limitation of ER alpha transcript levels but sustaining high levels of ER beta, reducing both activation of ER alpha target genes and cellular proliferation. The identification of ICB-1 as a new player in endocrine-related cancer encourages further studies on the significance of this gene in cancer development and therapy. Endocrine-Related Cancer (2010) 17 147-157
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | PROTEIN-COUPLED RECEPTOR; CYCLIN D1; CARCINOMA-CELLS; MESSENGER-RNA; EXPRESSION; BETA; GROWTH; PROLIFERATION; INVOLVEMENT; TAMOXIFEN; |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde) |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 05 Aug 2020 05:28 |
| Last Modified: | 05 Aug 2020 05:28 |
| URI: | https://pred.uni-regensburg.de/id/eprint/25026 |
Actions (login required)
 |
View Item |
